Figure (Per0b 0026 01)
Perseris
Product Images NDC 12496-0090
49 FDA label images from Indivior Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 49 technical images submitted to the FDA as part of the official labeling for Perseris (NDC 12496-0090). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Indivior Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure (Per0b 0026 02)
Figure (Per0b 0026 03)
Illustration showing three components used for an injectable product: a liquid syringe, a powder syringe, and a needle with a needle guard. Each item is depicted separately and labeled.*
Figure (Per0b 0026 04)
An instructional illustration showing a close-up of a hand holding a syringe. The syringe is positioned vertically with the plunger being pushed down by the thumb. The other hand is steadying the syringe near the top, demonstrating an injection or preparation technique. A red circle with the letter "P" is visible to the left.*
Figure (Per0b 0026 05)
An instructional illustration showing a hand holding two syringes with arrows indicating the removal of needle caps by twisting and pulling them off. The image focuses on safe preparation steps for the syringes.*
Figure (Per0b 0026 06)
An instructional line drawing illustrating how to properly hold a syringe for injection. The hands are shown stabilizing the syringe, with the plunger labeled 'L' and the injection point indicated by a red symbol labeled 'P'. This diagram likely serves as a step in administering PERSERIS injectable medication.*
Figure (Per0b 0026 07)
An instructional diagram illustrating the use of a syringe labeled with 'L' on the left side and 'P' on the right side, with arrows showing rotation directions. Below, a box displays '1 CYCLE =' with bidirectional arrows, indicating the motion cycle for syringe preparation or use. This diagram is related to PERSERIS by Indivior Inc.*
Figure (Per0b 0026 08)
An instructional illustration showing a step-by-step process of handling a syringe. The first step shows one hand pulling the plunger (marked P) downward while the other hand holds the barrel (marked L). The second step depicts turning the plunger (P) to engage with the part labeled L, indicating preparation for injection or priming. The image appears to guide proper syringe use related to PERSERIS by Indivior Inc.*
Figure (Per0b 0026 09)
An anatomical illustration showing the human torso with marked reference lines labeled 'Transpyloric Plane' and 'Transtubercular Plane.' Four boxes marked with 'X' indicate specific areas within the abdominal region, likely for medical or procedural reference.*
Figure (Per0b 0026 10)
An illustration showing the upper back and arm area of a human figure with two marked sites on the upper arms, likely indicating recommended injection locations for a medication. The figure is depicted from the back with two 'X' marks on each upper arm.*
Figure (Per0b 0026 11)
An instructional illustration showing the assembly of a syringe and needle, focusing on the connection process between the syringe barrel and the needle hub. The image is related to the preparation of PERSERIS, a medication by Indivior Inc.*
Figure (Per0b 0026 12)
An illustration depicting a hand holding a small object between the thumb and index finger. The image likely demonstrates a gripping or handling technique, possibly related to drug administration or packaging.*
Figure (Per0b 0026 13)
An instructional illustration showing a hand holding a syringe at a 45-degree angle. The syringe is being prepared for injection, with the needle pointing downward. This diagram likely demonstrates the proper angle for administration of an injection for PERSERIS by Indivior Inc.*
Figure (Per0b 0026 14)
An instructional illustration showing a hand holding a syringe with a needle, positioned above the forearm of another hand. An arrow points toward the forearm, indicating the direction or location for an injection.*
Figure (Per0b 0026 15)
An instructional illustration showing a hand holding a syringe with a needle, positioned above a vial or container with an arrow indicating the direction to insert or withdraw with the syringe. The image appears to be related to the preparation or administration of a medication, possibly PERSERIS.*
Figure (Per0b 0026 16)
Structural Formula (Per0b 0026 17)
Chemical structure of the active ingredient in PERSERIS by Indivior Inc., showing a complex organic molecule with multiple rings, including a fluorinated aromatic ring and a lactam moiety.*
Figure (Per0b 0026 18)
A line chart showing least square mean change with standard error over visits at Days 1, 15, 29, 43, and 57 for PERSERIS 90 mg, PERSERIS 120 mg, and placebo groups. Lines indicate decreasing trends for both PERSERIS doses compared to placebo. A table below the graph lists the number of patients at each visit for each group.*
Figure (Per0b 0026 19)
PERSERIS packaging label shows a white carton with purple and black text. The front panel displays the proprietary name PERSERIS prominently along with the labeler name Indivior Inc. No strength, active ingredient, dosage form, or package size details are visible in the image.*
Figure (Per0b 0026 20)
Figure (Per0b 0026 21)
Illustration showing two types of syringes labeled as Liquid Syringe and Powder Syringe, along with a separate image of a needle with a needle guard in its packaging. The diagram is related to the PERSERIS product by Indivior Inc.*
Figure (Per0b 0026 22)
PERSERIS packaging label from Indivior Inc. The label displays the product name prominently in large font with a white background featuring a pattern of interconnected geometric shapes. A blue and green circular motif is also present on the upper right side of the label. The overall design is clean and modern, emphasizing the brand name.*
Figure (Per0b 0026 23)
An instructional illustration showing a hand holding and flicking the top of a vial labeled with a 'P' symbol, demonstrating a preparation step likely related to PERSERIS, a product by Indivior Inc.*
Figure (Per0b 0026 24)
Figure (Per0b 0026 25)
An instructional illustration showing a hand holding an injectable product labeled PERSERIS. The image demonstrates the steps to prepare the injection, including removing the cap and mixing actions indicated by arrows. It visually guides the user through the preparation process for the PERSERIS injectable.*
Figure (Per0b 0026 26)
PERSERIS packaging label from Indivior Inc. The label includes caution information with a red triangle symbol. Additional text details are not fully legible.*
Figure (Per0b 0026 27)
An instructional diagram showing a hand holding a syringe with a plunger and barrel. The illustration highlights parts of the syringe labeled with 'L' and 'P', presumably indicating steps or components for preparing the medication PERSERIS.*
Figure (Per0b 0026 28)
Figure (Per0b 0026 29)
An instructional diagram illustrating the proper technique for administration using a syringe or injection device. The image features a hand holding the device, accompanied by an arrow and the label 'TIP' indicating an action or direction related to the procedure.*
Figure (Per0b 0026 30)
An instructional illustration showing hands holding a syringe labeled with 'L' and 'P' pointers and a cycle symbol explaining that one cycle equals two movements, indicated by arrows pointing left and right. This relates to the PERSERIS injectable product from Indivior Inc.*
Figure (Per0b 0026 31)
Figure (Per0b 0026 32)
A black and white text panel titled 'NOTE'. The panel contains an introductory paragraph explaining that PERSERIS is a once-monthly subcutaneous suspension of risperidone designed for extended release. The text describes the injection administration by a healthcare professional and emphasizes reading the full prescribing information. The panel offers an overview of the drug's administration and use instructions without detailed medical or dosing information.*
Figure (Per0b 0026 34)
An instructional illustration showing a red arrow and the text 'Turn the Page' indicating an action to flip the page, likely used in a user guide or medication instructions.*
Figure (Per0b 0026 33)
An instructional diagram showing the preparation steps for the PERSERIS injectable. It depicts hands holding a syringe and vial, with directional arrows indicating the steps of drawing medication into the syringe and rotating the plunger to mix or remove air prior to injection.*
Figure (Per0b 0026 35)
Figure (Per0b 0026 36)
An anatomical diagram showing the lower torso with labeled reference lines: the Transpyloric Plane near the upper abdomen and the Transtubercular Plane near the lower abdomen. Four marked spots around the navel area likely indicate injection sites or areas of interest.*
Figure (Per0b 0026 37)
An instructional illustration showing the recommended injection sites for PERSERIS on the human body. It highlights the upper outer areas of both arms as appropriate locations for administration.*
Figure (Per0b 0026 38)
A text panel titled 'NOTE' containing detailed information likely related to product instructions or warnings. The panel is densely packed with black text on a white background, formatted into multiple paragraphs. Specific product details are not discernible from this image alone.*
Figure (Per0b 0026 39)
Black and white line drawing showing a syringe drawing liquid from a vial. The vial has a scale and a plunger, indicating it is designed for injection preparation. The image depicts a step in medication preparation involving the syringe and vial, likely related to injectable drug administration.*
Figure (Per0b 0026 40)
Illustration depicting a hand holding a prefilled syringe with the thumb pressing on the plunger, demonstrating the injection process for administering the drug PERSERIS.*
Figure (Per0b 0026 41)
Figure (Per0b 0026 42)
A drug facts note panel accompanying PERSERIS, providing important usage information or instructions. The panel is a small square with an outlined border and the word 'NOTE' centered at the top in bold letters. The rest of the text is not legible in the image.*
Figure (Per0b 0026 43)
An instructional line drawing showing a hand holding a syringe at a 45-degree angle, preparing to administer an injection. The illustration highlights correct syringe positioning, with emphasis on the 45-degree angle for intramuscular or subcutaneous injection technique.*
Figure (Per0b 0026 44)
Packaging label for PERSERIS by Indivior Inc., featuring a white background with a red triangular caution symbol and the word 'CAUTION' in bold black text.*
Figure (Per0b 0026 45)
An instructional illustration shows a hand holding a syringe used for an injection into the upper arm of another person. The diagram indicates the injection site with an arrow pointing at the shoulder area below the skin surface.*
Figure (Per0b 0026 46)
An instructional illustration showing a hand holding a syringe with the needle cap being removed by pulling it off in an upward direction, indicated by an arrow. The diagram depicts proper syringe preparation, likely related to PERSERIS injection administration.*
Figure (Per0b 0026 47)
An instructional illustration showing a hand with fingers extended and a small dot above one fingertip, crossed out by a circle and diagonal line, indicating not to touch or press a certain area or substance, likely related to PERSERIS administration instructions.*
Principal Display Panel (Perseris Kit 90 mg Carton Label)
The packaging label for PERSERIS (risperidone) 90 mg extended-release injectable suspension by Indivior Inc. It is a once-monthly, single-dose injectable kit depicted with a powder syringe and liquid syringe for subcutaneous injection. The label includes storage instructions, kit contents, and a note that the product is for administration by healthcare professionals only.*
Principal Display Panel (Perseris Kit 120 mg Carton Label)
Packaging label for PERSERIS 120 mg (risperidone) extended-release injectable suspension by Indivior Inc. The label shows it is a single-dose kit for subcutaneous injection, including a liquid syringe and powder syringe for mixing before administration. Storage and usage instructions are also present.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
